Literature DB >> 31078633

Nosocomial infection by human bocavirus and human rhinovirus among paediatric patients with respiratory risks.

H Kobayashi1, M Shinjoh2, K Sudo3, S Kato3, M Morozumi4, G Koinuma1, T Takahashi5, Y Takano6, Y Tamura6, N Hasegawa6.   

Abstract

BACKGROUND: Nosocomial infections by respiratory viruses undetected by rapid tests are not often diagnosed. For paediatric patients with background diseases, nosocomial infection could be fatal. AIM: To determine the relationship between developing symptoms by respiratory viruses undetectable by rapid tests and respiratory risks and to improve the management of infection control.
METHODS: Two episodes of nosocomial infection by human bocavirus (HBoV) and human rhinovirus (HRV) were retrospectively investigated in a tertiary hospital paediatric ward in Japan. Viruses were identified by polymerase chain reaction to determine infection control management. When viruses of the same species were detected from different patients, the virus homology was investigated. The relationship between respiratory risks and developing symptoms was statistically investigated.
FINDINGS: Three and four patients with respiratory risks in the HBoV and HRV outbreaks, respectively, developed respiratory symptoms. The nucleotide sequences of two patients in the HBoV outbreak and all four patients in the HRV outbreak were phylogenetically close. In both outbreaks, the patients with respiratory risks developed significantly more symptoms than those without any risk (P = 0.035 and 0.018, respectively). After the patients with respiratory infection were separated from those with respiratory risks, no additional nosocomial infection occurred.
CONCLUSION: Patients with respiratory risks easily develop respiratory symptoms and acquire severe symptoms of nosocomial infection by those viruses. In a paediatric ward, we should adopt not only standard precautions but also isolation management of the patients with respiratory symptoms, even if they have negative results in rapid tests.
Copyright © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human bocavirus; Human rhinovirus; Infection control; Nosocomial infection; Polymerase chain reaction; Respiratory risks

Mesh:

Year:  2019        PMID: 31078633     DOI: 10.1016/j.jhin.2019.05.002

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

Review 1.  Ethanol is indispensable for virucidal hand antisepsis: memorandum from the alcohol-based hand rub (ABHR) Task Force, WHO Collaborating Centre on Patient Safety, and the Commission for Hospital Hygiene and Infection Prevention (KRINKO), Robert Koch Institute, Berlin, Germany.

Authors:  Axel Kramer; Mardjan Arvand; Bärbel Christiansen; Stephanie Dancer; Maren Eggers; Martin Exner; Dieter Müller; Nico T Mutters; Ingeborg Schwebke; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-06       Impact factor: 6.454

Review 2.  Emergent Pneumonia in Children.

Authors:  Cecilia Perret; Nicole Le Corre; Jose A Castro-Rodriguez
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418

3.  Bocavirus Infection in a Young Pregnant Woman: A Case Report and Literature Review.

Authors:  Ahmad Al Bishawi; Fatma Ben Abid; Wanis Ibrahim
Journal:  Am J Case Rep       Date:  2021-01-13

4.  Molecular evidence of rat bocavirus among rodents in Peninsular Malaysia.

Authors:  Siti Nurul Izzah Mohd-Azami; Shih Keng Loong; Jing Jing Khoo; Norhidayu Sahimin; Fang Shiang Lim; Nurul Aini Husin; Nur Hidayana Mahfodz; Farah Shafawati Mohd-Taib; Siti Nabilah Ishak; Benjamin L Makepeace; Sazaly Abubakar
Journal:  J Vet Med Sci       Date:  2022-05-18       Impact factor: 1.105

Review 5.  Seasonal Coronaviruses and Other Neglected Respiratory Viruses: A Global Perspective and a Local Snapshot.

Authors:  Sunčanica Ljubin-Sternak; Tomislav Meštrović; Ivana Lukšić; Maja Mijač; Jasmina Vraneš
Journal:  Front Public Health       Date:  2021-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.